The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
The clinical pharmacology of 6-mercaptopurine
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dithiothreitol, a New Protective Reagent for SH Groups*
Cleland, W. W. (1964) · Biochemistry · doi:10.1021/bi00892a002 · Cited by 1,992
Weinshilboum, R. M., & Sladek, S. L. (1980) · PubMed · Cited by 1,195
Treatment of Crohn's Disease with 6-Mercaptopurine: A Long-Term, Randomized, Double-Blind Study
Present, D. H., Korelitz, B. I., Wisch, N., Glass, J. L., Sachar, D. B., & Pasternack, B. S. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005013021801 · Cited by 1,042
The Metabolic Basis of Inherited Disease
Garland, J. T. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440180133052 · Cited by 652
Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia
Lennard, L., Lilleyman, J. S., Van Loon, J., & Weinshilboum, R. M. (1990) · The Lancet · doi:10.1016/0140-6736(90)91745-v · Cited by 651
Self-citationXanthine oxidase: biochemistry, distribution and physiology.
Parks, D. A., & Granger, D. N. (1986) · PubMed · Cited by 631
Lennard, L., Van Loon, J. A., & Weinshilboum, R. M. (1989) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1989.119 · Cited by 593
Self-citationProlonged Survival of Human-Kidney Homografts by Immunosuppressive Drug Therapy
Murray, J. E., Merrill, J. P., Harrison, J. H., Wilson, R. E., & Dammin, G. J. (1963) · New England Journal of Medicine · doi:10.1056/nejm196306132682401 · Cited by 549
BURCHENAL, J. H., MURPHY, M. L., ELLISON, R. R., SYKES, M. P., TAN, T. C., LEONE, L. A., KARNOF-SKY, D. A., CRAVER, L. F., DARGEON, H. W., & RHOADS, C. P. (1953) · Blood · doi:10.1182/blood.v8.11.965.965 · Cited by 397
Human erythrocyte thiopurine methyltransferase: Radiochemical microassay and biochemical properties
Weinshilboum, R. M., Raymond, F. A., & Pazmiño, P. A. (1978) · Clinica Chimica Acta · doi:10.1016/0009-8981(78)90311-x · Cited by 339
CONTROLLED TRIAL OF AZATHIOPRINE IN CROHN'S DISEASE
Willoughby, J. M. T., Beckett, J., Kumar, P., & Dawson, A. M. (1971) · The Lancet · doi:10.1016/s0140-6736(71)90268-6 · Cited by 314
Zimm, S., Collins, J. M., Riccardi, R., O'Neill, D., Narang, P. K., Chabner, B., & Poplack, D. G. (1983) · New England Journal of Medicine · doi:10.1056/nejm198304283081705 · Cited by 262
Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities
Kalow, W., & Tang, B.-K. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.176 · Cited by 261
Variability in caffeine metabolism
Grant, D. M., Tang, B. K., & Kalow, W. (1983) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1983.80 · Cited by 254
Effect of 6-Mercaptopurine on Antibody Production.
Schwartz, R., Stack, J., & Dameshek, W. (1958) · Experimental Biology and Medicine · doi:10.3181/00379727-99-24281 · Cited by 248
Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia.
Lennard, L., & Lilleyman, J. S. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.12.1816 · Cited by 244
Self-citationA STUDY OF THE EFFECTS OF DRUGS IN PROLONGING SURVIVAL OF HOMOLOGOUS RENAL TRANSPLANTS IN DOGS*
Calne, R. Y., Alexandre, G. P. J., & Murray, J. E. (1962) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1962.tb45358.x · Cited by 235
Drug dosage and remission duration in childhood lymphocytic leukemia
Pinkel, D. P., Hernandez, K., Borella, L. D., Holton, C. P., Aur, R. J. A., Samoy, G., & Pratt, C. B. (1971) · Cancer · Cited by 234
Overview of azathioprine treatment in multiple sclerosis
Yudkin, P. L., Ellison, G. W., Ghezzi, A., Goodkin, D. E., Hughes, R. A. C., McPherson, K., Mertin, J., & Milanese, C. (1991) · The Lancet · doi:10.1016/0140-6736(91)91909-e · Cited by 219
Yamada, M., Wasserman, R., Lange, B., Reichard, B. A., Womer, R. B., & Rovera, G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008163230705 · Cited by 200
CONTROLLED TRIAL OF AZATHIOPRINE IN CROHN'S DISEASE
Rhodes, J., Beck, P., Bainton, D., & Campbell, H. (1971) · The Lancet · doi:10.1016/s0140-6736(71)90598-8 · Cited by 184
Zimm, S., Collins, J. M., O'Neill, D., Chabner, B. A., & Poplack, D. G. (1983) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1983.254 · Cited by 173
Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease
O'Brien, J. J., Bayless, T. M., & Bayless, J. A. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90457-v · Cited by 172
Pai, G. S., Sprenkle, J. A., T, T., Mareni, C., & Migeon, B. R. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2810 · Cited by 157
Stothers, J. K., Boulton, F. E., Wild, R. A., Ibbotson, R. M., Milla, P. J., Lloyd, M., & Snodgrass, G. J. A. I. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91341-0 · Cited by 152
Flier, J. S., Moore, M. J., Wilson, J. M., Young, A. B., & Kelley, W. N. (1983) · New England Journal of Medicine · doi:10.1056/nejm198310133091507 · Cited by 144
Systemic Exposure to Mercaptopurine as a Prognostic Factor in Acute Lymphocytic Leukemia in Children
Koren, G., Ferrazzini, G., Sulh, H., Langevin, A. M., Kapelushnik, J., Klein, J., Giesbrecht, E., Soldin, S. J., & Greenberg, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230104 · Cited by 138
Chan, G. L. C., Erdmann, G. R., Gruber, S. A., Matas, A. J., & Canafax, D. M. (1990) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1990.tb03606.x · Cited by 120
Human liver xanthine oxidase: Nature and extent of individual variation
Guerciolini, R., Szumlanski, C. L., & Weinshilboum, R. M. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.205 · Cited by 116
Lennard, L. (1987) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(87)80340-7 · Cited by 101
Self-citationLennard, L., THOMAS, S., HARRINGTON, C. I., & Maddocks, J. L. (1985) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1985.tb02408.x · Cited by 97
Self-citationThiopurine methyltransferase biochemical genetics: Human lymphocyte activity
Loon, J. A. V., & Weinshilboum, R. M. (1982) · Biochemical Genetics · doi:10.1007/bf00483962 · Cited by 97
Inhibition of mammalian xanthine oxidase by folate compounds and amethopterin.
Lewis, A. S., Murphy, L., McCALLA, C., et al. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43612-x · Cited by 85
Zimm, S., Ettinger, L. J., Holcenberg, J. S., Kamen, B. A., Vietti, T. J., Belasco, J., Cogliano-Shutta, N. A., Balis, F. M., Lavi, L. E., & Collins, J. M. (1985) · PubMed · Cited by 81
TIDD, D. M., & Paterson, A. R. P. (1974) · PubMed · Cited by 79
Thiation of Nucleosides. III. Oxidation of 6-Mercaptopurines1
Doerr, I. L., Wempen, I., Clarke, D. A., & Fox, J. J. (1961) · The Journal of Organic Chemistry · doi:10.1021/jo01067a093 · Cited by 73
Azathioprine metabolism in kidney transplant recipients.
Lennard, L., Brown, C., Fox, M., et al. (1984) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1984.tb02531.x · Cited by 63
Self-citationPharmacogenetics of methylation: Relationship to drug metabolism
Weinshilboum, R. M. (1988) · Clinical Biochemistry · doi:10.1016/s0009-9120(88)80002-x · Cited by 61
Comparison between Mice Chimaeric and Heterozygous for the X-linked Gene tabby
McLaren, A. L. D., Gauld, I. K., & Bowman, P. (1973) · Nature · doi:10.1038/241180a0 · Cited by 55
Effect of allopurinol on caffeine disposition in man.
Grant, D. M., Tang, B., Campbell, M., & KALOW, W. (1986) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1986.tb05222.x · Cited by 54
QUANTITATION OF PLASMA AZATHIOPRINE AND 6-MERCAPTOPURINE LEVELS IN RENAL TRANSPLANT PATIENTS
Lin, S., Jessup, K., Floyd, M., et al. (1980) · Transplantation · doi:10.1097/00007890-198004000-00006 · Cited by 54
Bökkerink, J. P. M., Bakker, M. A. H., Hulscher, T. W., et al. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90625-8 · Cited by 53
PHOTOCHEMICAL SENSITIZATION BY AZATHIOPRINE AND ITS METABOLITES—I. 6‐MERCAPTOPURINE
Hemmens, V. J., & Moore, D. E. (1986) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1986.tb05601.x · Cited by 53
Bach, M., & Bach, J. (1972) · PubMed Central · Cited by 51
Odlind, B., Hartvig, P., Lindström, B., et al. (1986) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(86)90067-6 · Cited by 48
ENHANCEMENT OF UV‐INDUCED SKIN CARCINOGENESIS BY AZATHIOPRINE: ROLE OF PHOTOCHEMICAL SENSITISATION
KELLY, G. E., Meikle, W., & Moore, D. E. (1989) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1989.tb04078.x · Cited by 43
Schmiegelow, K., Schr�der, H., Pulczynska, M. K., & Hejl, M. (1989) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00694341 · Cited by 32
Photo-oxidation of 6-mercaptopurine in aqueous solution
Hemmens, V. J., & Moore, D. E. (1984) · Journal of the Chemical Society Perkin Transactions 2 · doi:10.1039/p29840000209 · Cited by 31
The metabolism of 2-amino-6-[(1-methyl-4-nitro-5-imidazolyl)thio]purine (B.W. 57-323) in man.
Elion, G. B., Sw, C., Hitchings, G. H., et al. (1960) · PubMed · Cited by 20
Cited by
EASL Clinical Practice Guidelines: autoimmune hepatitis
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.030 · Cited by 1,245
Nanomaterials for Theranostics: Recent Advances and Future Challenges
Lim, E.-K., Kim, T., Paik, S., Haam, S., Huh, Y.-M., & Lee, K. (2015) · Chemical Reviews · doi:10.1021/cr300213b · Cited by 1,233
Weinshilboum, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020021 · Cited by 1,031
Tiede, I., Fritz, G., Strand, S., Poppe, D., Dvorsky, R., Strand, D., Lehr, H. A., Wirtz, S., Becker, C., Atreya, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16432 · Cited by 828
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
Prefontaine, E., MacDonald, J. K., & Sutherland, L. R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000545.pub3 · Cited by 604
Metadata
- Authors
- Lennard, L.
- Venue
- European Journal of Clinical Pharmacology
- Published
- 1992-10
- Volume
- 43
- Issue
- 4
- Pages
- 329-339
- ISSN
- 0031-6970 (ISSN-L)
- 1432-1041
- OpenAlex
- W1967490229
- Cited by
- 647
- References
- 50
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.